Influenza A virus and TLR7 activation potentiate NOX2 oxidase-dependent ROS production in macrophages

Abstract Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an inflammatory response to resolve the infection. Macrophages are also major sources of reactive oxygen species (ROS) via the NOX2-containing N...

Full description

Saved in:
Bibliographic Details
Published inFree radical research Vol. 48; no. 8; pp. 940 - 947
Main Authors To, E. E., Broughton, B. R. S., Hendricks, K. S., Vlahos, R., Selemidis, S.
Format Journal Article
LanguageEnglish
Published England Informa Healthcare 01.08.2014
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an inflammatory response to resolve the infection. Macrophages are also major sources of reactive oxygen species (ROS) via the NOX2-containing NADPH oxidase. Although ROS are crucial for pathogen clearance, in response to influenza A virus, ROS are touted as being culprit mediators of the lung tissue injury. The aim of the present study was to determine whether influenza A virus infection and TLR7 activation of macrophages, results in alterations in their ROS production. Here we demonstrate using immunofluorescence that influenza A virus (Hong Kong X-31 strain; H3N2) internalizes in RAW264.7 cells and mouse alveolar macrophages within 1 h, resulting in a significant enhancement in the stimulated NOX2 oxidase-dependent oxidative burst, although virus had no effect on basal ROS. The specific TLR7 agonist imiquimod (10 μg/ml) elevated basal superoxide production and, in a similar fashion to influenza A virus, enhanced NOX2 oxidase-dependent oxidative burst. By contrast, the TLR3 agonist, poly I:C (1-100 μg/ml) failed to influence the oxidative burst to NOX2 oxidase. A peptide corresponding to the region 337-348 on p47phox conjugated to a HIV-tat, designed to inhibit the phosphorylation of Ser346 on p47phox suppressed the influenza A virus- and imiquimod-induced enhancement in the oxidative burst. In conclusion, this study demonstrates for the first time that influenza A virus and TLR7 activation enhance the NOX2 oxidase-dependent oxidative burst in macrophages, which might underpin the acute lung injury to influenza A virus infection.
AbstractList Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an inflammatory response to resolve the infection. Macrophages are also major sources of reactive oxygen species (ROS) via the NOX2-containing NADPH oxidase. Although ROS are crucial for pathogen clearance, in response to influenza A virus, ROS are touted as being culprit mediators of the lung tissue injury. The aim of the present study was to determine whether influenza A virus infection and TLR7 activation of macrophages, results in alterations in their ROS production. Here we demonstrate using immunofluorescence that influenza A virus (Hong Kong X-31 strain; H3N2) internalizes in RAW264.7 cells and mouse alveolar macrophages within 1 h, resulting in a significant enhancement in the stimulated NOX2 oxidase-dependent oxidative burst, although virus had no effect on basal ROS. The specific TLR7 agonist imiquimod (10 μg/ml) elevated basal superoxide production and, in a similar fashion to influenza A virus, enhanced NOX2 oxidase-dependent oxidative burst. By contrast, the TLR3 agonist, poly I:C (1-100 μg/ml) failed to influence the oxidative burst to NOX2 oxidase. A peptide corresponding to the region 337-348 on p47phox conjugated to a HIV-tat, designed to inhibit the phosphorylation of Ser346 on p47phox suppressed the influenza A virus- and imiquimod-induced enhancement in the oxidative burst. In conclusion, this study demonstrates for the first time that influenza A virus and TLR7 activation enhance the NOX2 oxidase-dependent oxidative burst in macrophages, which might underpin the acute lung injury to influenza A virus infection.
Abstract Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an inflammatory response to resolve the infection. Macrophages are also major sources of reactive oxygen species (ROS) via the NOX2-containing NADPH oxidase. Although ROS are crucial for pathogen clearance, in response to influenza A virus, ROS are touted as being culprit mediators of the lung tissue injury. The aim of the present study was to determine whether influenza A virus infection and TLR7 activation of macrophages, results in alterations in their ROS production. Here we demonstrate using immunofluorescence that influenza A virus (Hong Kong X-31 strain; H3N2) internalizes in RAW264.7 cells and mouse alveolar macrophages within 1 h, resulting in a significant enhancement in the stimulated NOX2 oxidase-dependent oxidative burst, although virus had no effect on basal ROS. The specific TLR7 agonist imiquimod (10 μg/ml) elevated basal superoxide production and, in a similar fashion to influenza A virus, enhanced NOX2 oxidase-dependent oxidative burst. By contrast, the TLR3 agonist, poly I:C (1-100 μg/ml) failed to influence the oxidative burst to NOX2 oxidase. A peptide corresponding to the region 337-348 on p47phox conjugated to a HIV-tat, designed to inhibit the phosphorylation of Ser346 on p47phox suppressed the influenza A virus- and imiquimod-induced enhancement in the oxidative burst. In conclusion, this study demonstrates for the first time that influenza A virus and TLR7 activation enhance the NOX2 oxidase-dependent oxidative burst in macrophages, which might underpin the acute lung injury to influenza A virus infection.
Author To, E. E.
Broughton, B. R. S.
Hendricks, K. S.
Selemidis, S.
Vlahos, R.
Author_xml – sequence: 1
  givenname: E. E.
  surname: To
  fullname: To, E. E.
  email: Stavros.selemidis@monash.edu, Stavros.selemidis@monash.edu
  organization: Department of Pharmacology, Monash University
– sequence: 2
  givenname: B. R. S.
  surname: Broughton
  fullname: Broughton, B. R. S.
  email: Stavros.selemidis@monash.edu, Stavros.selemidis@monash.edu
  organization: Department of Pharmacology, Monash University
– sequence: 3
  givenname: K. S.
  surname: Hendricks
  fullname: Hendricks, K. S.
  email: Stavros.selemidis@monash.edu, Stavros.selemidis@monash.edu
  organization: Department of Pharmacology, Monash University
– sequence: 4
  givenname: R.
  surname: Vlahos
  fullname: Vlahos, R.
  email: Stavros.selemidis@monash.edu, Stavros.selemidis@monash.edu
  organization: Department of Pharmacology & Therapeutics, Respiratory Research Group, Lung Health Research Centre, The University of Melbourne
– sequence: 5
  givenname: S.
  surname: Selemidis
  fullname: Selemidis, S.
  email: Stavros.selemidis@monash.edu, Stavros.selemidis@monash.edu
  organization: Department of Pharmacology, Monash University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24869957$$D View this record in MEDLINE/PubMed
BookMark eNp9kE9vFSEUxYmpsf_8BsawdDNPYKAMG03T2NrkxZe0NXFHGLjjo5mBEWZq208v42tN3HQDJPeccw-_Q7QXYgCE3lGyqilRHymRVMgTtmKE8pViUkj1Ch1QwlTFuCR7y1vSatHso8OcbwmhNRfyDdpnvDlRSsgDBJeh62cIjwaf4juf5oxNcPhmfSWxsZO_M5OPAY9xgjB5MwH-tvnBcLz3zmSoHIwQXBnhq801HlN0s_1r8AEPxqY4bs1PyMfodWf6DG-f7iP0_fzLzdnXar25uDw7XVeWN3yq6q5uRddaKmwjOWVdK2vuhGKEq65pDTgpCG_Lh4Qj5bAKiJDcKkINcQ3UR-jDLrc0-TVDnvTgs4W-NwHinDUVnNeMF0RFynfSUjLnBJ0ekx9MetCU6AWwfgasF8B6B7jY3j9tmNsB3D_TM9Ei-LwT-NDFNJjfMfVOT-ahj6lLJlifl_gXV3z6L2ELpp-21iTQt3FOoQB8ueMf0OCfAg
CitedBy_id crossref_primary_10_1007_s00216_020_02466_2
crossref_primary_10_1186_s11658_020_00211_2
crossref_primary_10_1124_mol_114_095216
crossref_primary_10_1016_j_intimp_2023_110943
crossref_primary_10_1038_s41598_019_38864_5
crossref_primary_10_1016_j_biopha_2024_116722
crossref_primary_10_1134_S0006297920120068
crossref_primary_10_1586_14787210_2015_1094375
crossref_primary_10_1016_j_mehy_2020_109910
crossref_primary_10_1038_s41467_017_00057_x
crossref_primary_10_1038_s41419_022_04775_z
crossref_primary_10_1002_jmv_25872
crossref_primary_10_1016_S1875_5364_19_30079_2
crossref_primary_10_1016_j_jep_2023_117290
crossref_primary_10_3390_medicina58060810
crossref_primary_10_1128_CMR_00094_21
crossref_primary_10_1007_s42770_021_00663_4
crossref_primary_10_3389_fimmu_2017_01177
crossref_primary_10_3390_ijms21114084
crossref_primary_10_1093_carcin_bgv126
crossref_primary_10_3390_antiox12020483
crossref_primary_10_1016_j_freeradbiomed_2017_08_027
crossref_primary_10_1186_s12864_017_3803_6
crossref_primary_10_1155_2020_6401341
crossref_primary_10_1080_10408398_2021_1972407
crossref_primary_10_1016_j_biopha_2020_110345
crossref_primary_10_1042_CS20140321
crossref_primary_10_3389_fmicb_2022_1111930
crossref_primary_10_1016_j_freeradbiomed_2018_06_011
crossref_primary_10_1016_j_phymed_2019_153150
crossref_primary_10_1155_2016_8910396
crossref_primary_10_3390_pathogens12070928
crossref_primary_10_1016_j_virol_2016_06_003
crossref_primary_10_1016_j_biopha_2022_114000
crossref_primary_10_1016_j_antiviral_2017_04_010
crossref_primary_10_1155_2022_5589089
crossref_primary_10_3390_clinpract12040063
crossref_primary_10_1002_rmv_2240
crossref_primary_10_1007_s13258_020_01021_8
crossref_primary_10_1186_s12985_015_0284_6
crossref_primary_10_1371_journal_ppat_1004566
crossref_primary_10_3390_v8100269
crossref_primary_10_3389_fcimb_2021_804976
crossref_primary_10_1016_j_bbagen_2018_03_004
crossref_primary_10_3389_fphar_2024_1309682
crossref_primary_10_1016_j_cytogfr_2020_08_002
crossref_primary_10_1042_CS20210050
crossref_primary_10_1051_medsci_20183406028
crossref_primary_10_3892_mmr_2018_9089
crossref_primary_10_56294_saludcyt2023239
crossref_primary_10_1099_jgv_0_001961
crossref_primary_10_31857_S0320972520120064
crossref_primary_10_3390_antiox11081488
crossref_primary_10_1016_j_jdermsci_2015_12_011
crossref_primary_10_1186_s12985_020_01463_2
crossref_primary_10_1016_j_pupt_2015_06_006
crossref_primary_10_3390_v10080392
crossref_primary_10_1152_ajplung_00231_2016
crossref_primary_10_3390_nu12030616
crossref_primary_10_1111_imm_12530
Cites_doi 10.4049/jimmunol.1201007
10.1126/science.1093616
10.1016/j.cell.2008.02.043
10.1165/rcmb.2011-0345OC
10.1371/journal.ppat.1001329
10.4049/jimmunol.164.11.5998
10.1073/pnas.93.6.2448
10.1016/j.freeradbiomed.2013.10.014
10.1038/nsmb769
10.1371/journal.pone.0048326
10.1038/sj.icb.7100026
10.1038/nrd3403
10.1128/JVI.76.20.10455-10464.2002
10.4049/jimmunol.1202574
10.1172/JCI27544
10.1007/s00281-008-0118-3
10.1002/eji.200635977
10.1016/S0092-8674(03)00314-3
10.4049/jimmunol.171.8.4392
10.1038/nri1630
10.1172/JCI114496
10.1189/jlb.0804442
10.1016/j.tips.2011.09.001
10.4049/jimmunol.178.6.3368
10.1016/j.pharmthera.2008.08.005
10.1371/journal.ppat.1001271
10.1016/j.virusres.2013.09.011
10.1007/s11427-009-0061-0
10.1152/physrev.00044.2005
10.1146/annurev-immunol-030409-101335
ContentType Journal Article
Copyright 2014 Informa UK, Ltd. 2014
Copyright_xml – notice: 2014 Informa UK, Ltd. 2014
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.3109/10715762.2014.927579
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1029-2470
EndPage 947
ExternalDocumentID 10_3109_10715762_2014_927579
24869957
927579
Genre Original Articles
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.HR
00X
03L
0BK
0R~
29H
30N
36B
4.4
53G
5GY
5VS
A8Z
AAAVI
AAGME
AAJMT
AALDU
AALIY
AAMIU
AAOAP
AAPUL
AAPXX
AAQRR
ABBKH
ABCCY
ABDBF
ABFIM
ABJVF
ABJYH
ABLIJ
ABLKL
ABPTK
ABQHQ
ABXUL
ACBBU
ACDHJ
ACFUF
ACGEJ
ACGFS
ACQMU
ACTIO
ADCVX
ADFCX
ADGTB
ADGTR
ADOPC
ADRBQ
ADXPE
AEGYZ
AEISY
AENEX
AEOZL
AEPSL
AEYOC
AEYQI
AFDYB
AFFNX
AFKVX
AFOSN
AFWLO
AGDLA
AHDLD
AIJEM
AIRXU
AJWEG
AKBVH
AKOOK
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
APNXG
AQRUH
AURDB
AWQZV
AWYRJ
BABNJ
BFWEY
BLEHA
CAG
CCCUG
COF
CS3
CWRZV
DGEBU
DKSSO
DU5
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
EST
ESX
F5P
H13
HGUVV
HZ~
J.N
JEPSP
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M44
M4Z
MM.
O9-
OWHGL
P2P
PCLFJ
RNANH
RNS
ROSJB
RTWRZ
SV3
TFDNU
TFL
TFT
TFW
TQWBC
TTHFI
TUS
V1S
Z0Y
ZGOLN
ZXP
~1N
ABFMO
ABJNI
ABPAQ
ABTAA
ABXYU
AHDZW
CGR
CUY
CVF
ECM
EIF
ESTFP
NPM
NUSFT
TBQAZ
TDBHL
TUROJ
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c484t-3f3b5fbc15c87412fb734d592049f8baed7504b7625d0625c9e0574c901a0d8e3
ISSN 1071-5762
IngestDate Sat Oct 26 00:40:38 EDT 2024
Fri Aug 23 03:08:42 EDT 2024
Tue Oct 15 23:51:55 EDT 2024
Tue Jun 13 19:29:44 EDT 2023
Wed Jun 21 01:44:23 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords superoxide
poly I:C
oxidative stress
imiquimod
lung pathology
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c484t-3f3b5fbc15c87412fb734d592049f8baed7504b7625d0625c9e0574c901a0d8e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24869957
PQID 1544324029
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1544324029
crossref_primary_10_3109_10715762_2014_927579
informaworld_taylorfrancis_310_3109_10715762_2014_927579
pubmed_primary_24869957
informahealthcare_journals_10_3109_10715762_2014_927579
PublicationCentury 2000
PublicationDate 2014-08-01
PublicationDateYYYYMMDD 2014-08-01
PublicationDate_xml – month: 08
  year: 2014
  text: 2014-08-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Free radical research
PublicationTitleAlternate Free Radic Res
PublicationYear 2014
Publisher Informa Healthcare
Taylor & Francis
Publisher_xml – name: Informa Healthcare
– name: Taylor & Francis
References CIT0010
CIT0011
Vlahos R (CIT0002) 2012; 33
Snelgrove RJ (CIT0014) 2006; 36
Groemping Y (CIT0013) 2003; 113
Yatmaz S (CIT0008) 2013; 48
Dang PMC (CIT0020) 2006; 116
CIT0016
CIT0015
CIT0018
CIT0017
Le Goffic R (CIT0029) 2007; 178
Kash JC (CIT0005) 2014; 67
CIT0021
Akaike T (CIT0003) 1996; 93
Lee YH (CIT0006) 2013; 178
CIT0023
El-Benna J (CIT0025) 2008; 30
La Gruta NL (CIT0001) 2007; 85
Harrison CB (CIT0012) 2012; 7
Wang H (CIT0022) 2009; 52
CIT0024
Makni-Maalej K (CIT0030) 2012; 189
Vlahos R (CIT0007) 2011; 7
CIT0004
CIT0026
Sheppard FR (CIT0027) 2005; 78
Yang CS (CIT0019) 2013; 190
CIT0028
CIT0009
References_xml – volume: 189
  start-page: 4657
  year: 2012
  ident: CIT0030
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1201007
  contributor:
    fullname: Makni-Maalej K
– ident: CIT0017
  doi: 10.1126/science.1093616
– ident: CIT0004
  doi: 10.1016/j.cell.2008.02.043
– volume: 48
  start-page: 17
  year: 2013
  ident: CIT0008
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2011-0345OC
  contributor:
    fullname: Yatmaz S
– ident: CIT0021
  doi: 10.1371/journal.ppat.1001329
– ident: CIT0018
  doi: 10.4049/jimmunol.164.11.5998
– volume: 93
  start-page: 2448
  year: 1996
  ident: CIT0003
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.93.6.2448
  contributor:
    fullname: Akaike T
– volume: 67
  start-page: 235
  year: 2014
  ident: CIT0005
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2013.10.014
  contributor:
    fullname: Kash JC
– ident: CIT0023
  doi: 10.1038/nsmb769
– volume: 7
  start-page: e48326
  year: 2012
  ident: CIT0012
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0048326
  contributor:
    fullname: Harrison CB
– volume: 85
  start-page: 85
  year: 2007
  ident: CIT0001
  publication-title: Immunol Cell Biol
  doi: 10.1038/sj.icb.7100026
  contributor:
    fullname: La Gruta NL
– ident: CIT0010
  doi: 10.1038/nrd3403
– ident: CIT0024
  doi: 10.1128/JVI.76.20.10455-10464.2002
– volume: 190
  start-page: 6368
  year: 2013
  ident: CIT0019
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1202574
  contributor:
    fullname: Yang CS
– volume: 116
  start-page: 2033
  year: 2006
  ident: CIT0020
  publication-title: J Clin Invest
  doi: 10.1172/JCI27544
  contributor:
    fullname: Dang PMC
– volume: 30
  start-page: 279
  year: 2008
  ident: CIT0025
  publication-title: Semin Immunopathol
  doi: 10.1007/s00281-008-0118-3
  contributor:
    fullname: El-Benna J
– volume: 36
  start-page: 1364
  year: 2006
  ident: CIT0014
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200635977
  contributor:
    fullname: Snelgrove RJ
– volume: 113
  start-page: 343
  year: 2003
  ident: CIT0013
  publication-title: Cell
  doi: 10.1016/S0092-8674(03)00314-3
  contributor:
    fullname: Groemping Y
– ident: CIT0028
  doi: 10.4049/jimmunol.171.8.4392
– ident: CIT0016
  doi: 10.1038/nri1630
– ident: CIT0026
  doi: 10.1172/JCI114496
– volume: 78
  start-page: 1025
  year: 2005
  ident: CIT0027
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0804442
  contributor:
    fullname: Sheppard FR
– volume: 33
  start-page: 3
  year: 2012
  ident: CIT0002
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2011.09.001
  contributor:
    fullname: Vlahos R
– volume: 178
  start-page: 3368
  year: 2007
  ident: CIT0029
  publication-title: J Immunol
  doi: 10.4049/jimmunol.178.6.3368
  contributor:
    fullname: Le Goffic R
– ident: CIT0011
  doi: 10.1016/j.pharmthera.2008.08.005
– volume: 7
  start-page: 1001271
  year: 2011
  ident: CIT0007
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1001271
  contributor:
    fullname: Vlahos R
– volume: 178
  start-page: 411
  year: 2013
  ident: CIT0006
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2013.09.011
  contributor:
    fullname: Lee YH
– volume: 52
  start-page: 464
  year: 2009
  ident: CIT0022
  publication-title: Sci China C Life Sci
  doi: 10.1007/s11427-009-0061-0
  contributor:
    fullname: Wang H
– ident: CIT0009
  doi: 10.1152/physrev.00044.2005
– ident: CIT0015
  doi: 10.1146/annurev-immunol-030409-101335
SSID ssj0013457
Score 2.3855548
Snippet Abstract Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an...
Influenza A virus infects resident alveolar macrophages in the respiratory tract resulting in Toll like receptor 7 (TLR7) activation that triggers an...
SourceID proquest
crossref
pubmed
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Publisher
StartPage 940
SubjectTerms Animals
Humans
imiquimod
Influenza A virus - genetics
Influenza A virus - metabolism
lung pathology
Macrophages - metabolism
Male
Membrane Glycoproteins - metabolism
Mice
Mice, Inbred C57BL
NADPH Oxidase 2
NADPH Oxidases - metabolism
Oxidative Stress
Phosphorylation
poly I:C
Reactive Oxygen Species - metabolism
Signal Transduction
superoxide
Toll-Like Receptor 7 - genetics
Toll-Like Receptor 7 - metabolism
Title Influenza A virus and TLR7 activation potentiate NOX2 oxidase-dependent ROS production in macrophages
URI https://www.tandfonline.com/doi/abs/10.3109/10715762.2014.927579
https://www.ncbi.nlm.nih.gov/pubmed/24869957
https://search.proquest.com/docview/1544324029
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgk4AXNMZt3GQk3qKMxrET-7Ebm8plm1Q6MfESOY6jVmJN1aUI7ddzfMmFbuP2ElVJEyv5vpycc3z8HYTecCZFrAgNhZAQoLAkDzmNeDhgmmhOCqZtvuPoOBmd0g9nrDfRbleX1Pmuurx2Xcn_oAr7AFezSvYfkG0vCjvgN-ALW0AYtn-F8XvXYeRSwuv9fbZcOb3lyadxajUyXLY1WFS1KQkCpzI4PjkjQfVjVsC3K2z639bB-OSzKdQqnJKsSYGcS9PaawrG5qLvvh4utQ6W0s3teJ2gNp88sVnXg25tw55tAeTr8_eCcZdmHcHARo_fkuhjr-3XNzmtenWMPh0R0bYYDr4mzoSaghpCXTuQxsZS3uMS7xlM4cSa1g157HRQITaNICAyC-YiuitIylznmR62i3MLLqE8EcJpXa8JaDeHbqNNAtYIzODmcPTu65dusomy1K2qNMO-vW5QoxntL_OLA7Pl5W2nbbHemuTtzYGLdWAmW-i-jzzw0NHoAbql59vo7n7T8G8b3TnydRYPkW6ZhYfYMgsDs7BhFu6YhTtmYcMsfIVZGJiFO2bh2Rz3mPUInR4eTPZHoW_IESrKaR3GZZyzMlcRUxw8UVLmaUwLJgiEmSXPpS5Ms4Acnh0rBrBRQkM4QBX4nHJQcB0_Rhvzaq6fIixKUiSSQ3CiSqoZl1rxksLnJVEAUVHuoLB5ytnC6a5kEK8agLIGoMwAlDmAdlB6BYrMv6oXfziT9wHLapspK11bG3Pa70593YCbAVZmqk3OdbWCAY2spJm4hP88cai3t9EQ6dmNR56je92r9QJt1MuVfgm-b52_8tz9CZJGpss
link.rule.ids 315,783,787,27936,27937,60214,61003,61689,61870
linkProvider Library Specific Holdings
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELZgSGwvMAYbG7-MxKtL4tiJ_ThNmzpoO2l00t4sx7G1CpFWa4rQ_vrdxclgQwMJXpKH5OKcfba_s8_fEfJBSaszxwXT2oKDIvOSKZEqlkjPveKV9O16x3iSD8_Ep3PZRxMuu7BK9KFDJIpox2rs3LgY_bF1MRMN9yIFnIznqFIx0LyQhX5IHuUpGB-e4kgmPzcSREv2iRIMReLpuXu_cmt22uy4Sy9uIrHu8Jnej0rb2enoKSl7vWJQytfBqikH7uoO5eN_Kb5JnnTYle5HY3tGHvh6i6wf9CnjtsjjcbdT_5z445j95MrSffp9drlaUiiWTkenBcWzFHElmC7mDYYrAeClk5NzTuc_ZhXMq6zPzdvQ05MvdBFpaVFgVtNvFtOOXcBAuHxBzo4OpwdD1qV0YE4o0bAsZKUMpUulU4BleCiLTFRSc3BUgiqtr5BuvgQVZZXAxWkPgFI4QC02qZTPtslaPa_9S0J14FVuFcBbF4SXynqngoABKnc6y6uwS1jflGYRmTsMeDxYj6avR4P1aGI97pLit_Y2XYde_kVS_WoVpmnXWkJMjIJifxJ931uQgbbCzRpb-_kKCkRiQtz6gnd2omndqMGFyrWWxd4___I7sj6cjkdmdDz5_Ips4JMY1fiarDWXK_8GkFZTvm370jWbxxin
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSIULlPIqTyNx9ZI4dmIfq8KqhXaLSivtzXL8UFeI7KqbRai_npk4KaWoIMElOSQTx_bY_sae-YaQN0paXTgumNYWDBRZ1kyJXLFMBh4U9zJ0-x0Hk3L3RHyYyumlKH50q0QbOiaiiG6uxsG98PFtZ2FmGu5VDjAZw6hyMdK8kpW-SW6VealQr4ts8vMcQXRcnyjBUCQFz137lV8Wp42euvT0whHrCp3p9aC0W5zG94gdqpV8Ur6MVm09cudXGB__p94b5G6PXOl2UrX75EZoNsntnSFh3CZZP-jP6R-QsJdyn5xbuk2_zc5WSwql0uP9o4piJEXaB6aLeYvOSgB36eRwyun8-8zDqsqGzLwtPTr8TBeJlBYFZg39ajHp2ClMg8uH5GT8_nhnl_UJHZgTSrSsiEUtY-1y6RQgGR7rqhBeag5mSlS1DR7J5muoovQZXJwOACeFA8xiM69C8YisNfMmPCFUR-5LqwDcuiiCVDY4FQVMT6XTRenjFmFDT5pF4u0wYO9gO5qhHQ22o0ntuEWq37rb9MN5-RdJdVkpTNvttMSUFgXF_iT6elAgA32FRzW2CfMVFIi0hHjwBe88Tpp1UQ0uVKm1rJ7-8y-_Iuuf3o3N_t7k4zNyBx8kl8bnZK09W4UXALPa-mU3kn4AS7gXXw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influenza+A+virus+and+TLR7+activation+potentiate+NOX2+oxidase-dependent+ROS+production+in+macrophages&rft.jtitle=Free+radical+research&rft.au=To%2C+E+E&rft.au=Broughton%2C+B+R+S&rft.au=Hendricks%2C+K+S&rft.au=Vlahos%2C+R&rft.date=2014-08-01&rft.eissn=1029-2470&rft.volume=48&rft.issue=8&rft.spage=940&rft_id=info:doi/10.3109%2F10715762.2014.927579&rft_id=info%3Apmid%2F24869957&rft.externalDocID=24869957
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1071-5762&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1071-5762&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1071-5762&client=summon